HUE072115T2 - Eszköz és eljárás narancsbõr felmérésére és kezelésére - Google Patents

Eszköz és eljárás narancsbõr felmérésére és kezelésére

Info

Publication number
HUE072115T2
HUE072115T2 HUE18713447A HUE18713447A HUE072115T2 HU E072115 T2 HUE072115 T2 HU E072115T2 HU E18713447 A HUE18713447 A HU E18713447A HU E18713447 A HUE18713447 A HU E18713447A HU E072115 T2 HUE072115 T2 HU E072115T2
Authority
HU
Hungary
Prior art keywords
assessing
treating cellulite
cellulite
treating
Prior art date
Application number
HUE18713447A
Other languages
English (en)
Hungarian (hu)
Inventor
Jeffrey Davidson
Michael Mclane
Genzhou Liu
Original Assignee
Endo Operations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Operations Ltd filed Critical Endo Operations Ltd
Publication of HUE072115T2 publication Critical patent/HUE072115T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4848Monitoring or testing the effects of treatment, e.g. of medication
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24003Microbial collagenase (3.4.24.3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1079Measuring physical dimensions, e.g. size of the entire body or parts thereof using optical or photographic means

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
HUE18713447A 2017-03-01 2018-03-01 Eszköz és eljárás narancsbõr felmérésére és kezelésére HUE072115T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762465622P 2017-03-01 2017-03-01
US201762485705P 2017-04-14 2017-04-14
US201762607188P 2017-12-18 2017-12-18

Publications (1)

Publication Number Publication Date
HUE072115T2 true HUE072115T2 (hu) 2025-10-28

Family

ID=61768443

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18713447A HUE072115T2 (hu) 2017-03-01 2018-03-01 Eszköz és eljárás narancsbõr felmérésére és kezelésére

Country Status (18)

Country Link
US (4) US11123280B2 (enExample)
EP (2) EP4591945A2 (enExample)
JP (2) JP7558654B2 (enExample)
KR (3) KR20230003601A (enExample)
CN (2) CN115969318A (enExample)
AU (4) AU2018226820B2 (enExample)
BR (1) BR112019018277A2 (enExample)
CA (1) CA3055041A1 (enExample)
DK (1) DK3589204T3 (enExample)
ES (1) ES3036011T3 (enExample)
FI (1) FI3589204T3 (enExample)
HU (1) HUE072115T2 (enExample)
IL (2) IL301796A (enExample)
MX (2) MX2023015506A (enExample)
NZ (1) NZ756787A (enExample)
PL (1) PL3589204T3 (enExample)
PT (1) PT3589204T (enExample)
WO (1) WO2018160905A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
AU2018244426B2 (en) 2017-03-28 2024-09-19 Endo Ventures Limited Improved method of producing collagenase
WO2020021332A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021330A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020058755A1 (en) 2018-09-18 2020-03-26 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
KR20210113271A (ko) * 2019-01-06 2021-09-15 엔도 글로벌 에스테틱스 리미티드 콜라게나제 제형 및 이의 제조 방법
US12262976B2 (en) 2019-03-13 2025-04-01 Blossom Innovations Llc Devices, systems and methods for tissue analysis, location determination and therapy thereof using optical radiation
TW202100099A (zh) 2019-03-13 2021-01-01 美商布羅盛創新有限責任公司 使用光學輻射之組織分析、位置測定及其治療之裝置、系統及方法
US11432733B2 (en) 2019-03-13 2022-09-06 Blossom Innovations Tissue detection devices, systems and methods
CN113033528A (zh) * 2021-05-27 2021-06-25 明品云(北京)数据科技有限公司 一种反馈量表评估方法、系统、设备和介质

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821364A (en) 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
JPS5662229A (en) 1979-10-25 1981-05-28 Asahi Glass Co Ltd Electro-optical dimming panel
US4338300A (en) 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
CA1227132A (fr) 1983-01-05 1987-09-22 Robert J. Weill Preparation a activite collagenolytique ayant une activite elevee et compositions pharmaceutiques la contenant
US4524065A (en) 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US5252461A (en) 1990-05-01 1993-10-12 The Regents Of The Univ. Of California Mixed immunoglobulins for detection of rheumatoid factors
CA2047306A1 (en) 1990-07-23 1992-01-24 Milan Holjevac Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
US5393792A (en) 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5462739A (en) 1991-11-21 1995-10-31 Yeda Research And Development Co., Ltd. Microdelivery device and method for enhanced drug administration to the eye
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
WO1994000580A1 (en) 1992-06-22 1994-01-06 Trigen, Inc. Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum
JP3186881B2 (ja) 1993-02-18 2001-07-11 倉敷紡績株式会社 肝細胞の分離方法
US5332503A (en) 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
CA2189646C (en) 1994-06-24 1999-05-25 Francis E. Dwulet A purified mixture of collagenases and two other proteases obtained from clostridium histolyticum
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
CA2158822C (en) 1994-09-27 2008-12-23 Kusuki Nishioka Therapeutic agent for rheumatic disease
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
PL322271A1 (en) 1995-03-16 1998-01-19 Knoll Ag Novel defined mixtures of enzymes for use in growing cells and healing wounds
IT1279011B1 (it) 1995-06-15 1997-12-02 Ips Int Prod Services Apparecchiatura per la rilevazione e scelta dei trattamenti della cellulite
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
JP2001510331A (ja) 1996-11-19 2001-07-31 ロシュ ダイアグノスティックス ゲーエムベーハー クロストリジウム・ヒストリチカム由来の組換えコラゲナーゼタイプ▲i▼および細胞と細胞群の単離へのその使用
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US5753785A (en) 1996-12-16 1998-05-19 Fina Technology, Inc. Production of E-B copolymers with a single metallocene catalyst and a single monomer
US6086872A (en) 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
JPH10262658A (ja) 1997-03-28 1998-10-06 Kikkoman Corp ザルコシン・オキシダーゼの結晶、その製造方法及び三次元構造
CA2317066A1 (en) 1997-10-03 1999-04-15 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
GB9724802D0 (en) 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US20020036328A1 (en) 1998-11-16 2002-03-28 William R. Richards, Jr. Offset drain fermi-threshold field effect transistors
FR2788682B1 (fr) * 1999-01-26 2001-04-06 Seb Sa Dispositif de thermographie
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
RU2180002C2 (ru) 1999-08-16 2002-02-27 Пермское научно-производственное объединение "Биомед" Способ получения коллагеназы
WO2001013865A1 (en) 1999-08-20 2001-03-01 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US6280993B1 (en) 1999-08-24 2001-08-28 Ichiro Yamato Gene encoding class I collagenase
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
DK2363142T3 (en) 1999-09-24 2015-04-20 Proteon Therapeutics Inc Elastase for opening the closed biological channels
US20030026844A1 (en) 2000-04-18 2003-02-06 Hee-Yong Lee Injectable sustained release pharmaceutical composition and processes for preparing the same
DK1355566T3 (da) 2000-12-18 2013-03-04 Univ Texas Lokal regional kemoterapi og radioterapi ved anvendelse af hydrogel in situ
US20030022856A1 (en) 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
CA2447818C (en) 2001-07-02 2011-01-04 Nordmark Arzneimittel Gmbh & Co. Kg Method for purifying an enzyme and purified enzyme produced according to this method, as well as use of the enzyme
GB0124124D0 (en) 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
ES2300569T3 (es) * 2002-03-15 2008-06-16 The General Hospital Corporation Dispositivos para la perturbacion selectiva de tejido graso mediante enfriamiento controlado.
JP2003284553A (ja) 2002-03-28 2003-10-07 Seikagaku Kogyo Co Ltd 生理活性タンパク質
CN1662177A (zh) * 2002-06-25 2005-08-31 超形态公司 用于形体美学的设备和方法
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
EP1462519A1 (en) 2003-03-24 2004-09-29 Boehringer Ingelheim Austria GmbH Method and devices for producing biomolecules
JP4205496B2 (ja) 2003-06-19 2009-01-07 三菱化学株式会社 新規カルボニル還元酵素及びこれをコードするdna、ならびにこれらを利用した光学活性アルコールの製造方法
WO2005073367A1 (en) 2004-01-30 2005-08-11 Zymenex A/S Production and purification of recombinant arylsulfatase a
US8147428B2 (en) * 2004-04-16 2012-04-03 University Of Massachusetts Device and method for quantifying edema
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ATE521355T1 (de) 2004-05-19 2011-09-15 Los Angeles Biomed Res Inst Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
HRP20090343T1 (hr) 2004-07-07 2009-07-31 H. Lundbeck A/S Novi karbamilirani epo i postupak za njegovu proizvodnju
MX2007000216A (es) 2004-07-08 2007-03-15 Amgen Inc Peptidos terapeuticos.
WO2006025226A1 (ja) 2004-08-30 2006-03-09 Daicel Chemical Industries, Ltd. ポリグリセリンモノエーテル及びその製造方法
US20150025420A1 (en) * 2004-10-06 2015-01-22 Guided Therapy Systems, Llc Ultrasound treatment device and methods of use
DE102004060075A1 (de) 2004-12-14 2006-07-06 Merck Patent Gmbh Verfahren zur Herstellung von Onium-Salzen mit Dialkylphosphat-, Dialkylphosphinat oder (O-Alkyl)-alkyl- oder Alkyl-phosphonat-Anionen mit geringem Halogenid-Gehalt
SI1846022T1 (sl) 2005-01-21 2016-01-29 The Research Foundation Of State University Of New York Postopki za zdravljenje adhezivnega kapsulitisa
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
JP2006254876A (ja) 2005-03-18 2006-09-28 Hokkaido Univ L−トリプトファン製造法
US20060251581A1 (en) 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US20070003541A1 (en) 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
JP3122177U (ja) * 2005-09-28 2006-06-08 株式会社資生堂 セルライトの診断基準シート
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
CN102015030A (zh) * 2006-03-31 2011-04-13 帝斯曼知识产权资产管理有限公司 化合物和化合物的组合用于改善身体外观的新型用途
WO2008100833A2 (en) 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
WO2008101406A1 (en) 2007-02-14 2008-08-28 Yolare Dermaceuticals, Llc Modified mutant collagenase and it's use in fat melting and in scar reduction
KR20100017333A (ko) * 2007-05-11 2010-02-16 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 화장료 유효 성분의 전달에 유용한 젤
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
WO2009059379A1 (en) 2007-11-07 2009-05-14 Dynamic Microbials Limited Antimicrobial compositions, formulations and uses thereof
US20100159564A1 (en) 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
ES2388219T3 (es) 2008-06-02 2012-10-10 F. Hoffmann-La Roche Ag Purificación mejorada de colagenasas a partir de un cultivo líquido de Clostridium histolyticum
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
AU2009274229B2 (en) 2008-07-21 2013-08-22 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8380531B2 (en) 2008-07-25 2013-02-19 Invivodata, Inc. Clinical trial endpoint development process
WO2010048409A1 (en) * 2008-10-22 2010-04-29 Allergan, Inc. Clinical assessment scales and methods
BRPI0921679A2 (pt) * 2008-11-11 2016-02-16 Sigma Tau Ind Farmaceuti composto útil para tratar celulite
JP5698536B2 (ja) 2008-11-19 2015-04-08 Meiji Seikaファルマ株式会社 アフィニティタグが結合した融合コラゲナーゼおよびその製造法
IT1397646B1 (it) 2009-12-15 2013-01-18 Seidita Collagenasi ricombinanti di c. histolyticum e metodo per la loro produzione.
US9132199B2 (en) 2010-03-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Reverse thermal gels and uses therefor
WO2011130537A2 (en) 2010-04-14 2011-10-20 Northwestern University Pharmaceutical compositions and methods for digesting atherosclerotic plaques
WO2012024635A2 (en) * 2010-08-19 2012-02-23 Medicis Pharmaceutical Corporation Mid-face aesthetic scale and related methods
WO2012031245A1 (en) 2010-09-03 2012-03-08 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
MX363465B (es) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Tratamiento de la grasa submental.
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
TWI461214B (zh) 2011-06-13 2014-11-21 Univ Chang Gung Biodegradable water-sensitive glue, a drug delivery system as a carrier thereof, and a pharmaceutical composition for the treatment and / or prevention of eye diseases
US9333005B2 (en) * 2011-10-17 2016-05-10 Sound Surgical Technologies Llc Ultrasonic probe for treating cellulite
PT2768523T (pt) * 2011-10-21 2019-08-29 Endo Global Ventures Processo para tratar ou reduzir a efp
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
JP2015506247A (ja) * 2012-01-27 2015-03-02 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 皺重症度を測定するための方法及び評価スケール
JP6049862B2 (ja) * 2012-09-07 2016-12-21 株式会社 資生堂 フィブリン3及び/又はサルコグリカンγを指標としたセルライトの評価方法及びセルライト効果薬剤の評価方法
US20160000890A1 (en) 2013-03-15 2016-01-07 Biospecifics Technologies Corp. Thermosensitive hydrogel collagenase formulations
US9463155B2 (en) * 2013-03-15 2016-10-11 Mary Kay Inc. Cosmetic compositions and uses thereof
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
US10729700B2 (en) * 2014-06-27 2020-08-04 Medytox Inc. Methods and compositions of bile acids and salts for reduction of fat
CA3013776A1 (en) 2016-02-08 2017-08-17 OutcomeMD, Inc. Determining a wellness, improvement, or effectiveness score
US11344573B2 (en) * 2016-10-28 2022-05-31 Merz Pharma Gmbh & Co. Kgaa Treatment of gynoid lipodystrophy
DK3589204T3 (da) 2017-03-01 2025-06-30 Endo Operations Ltd Apparat og fremgangsmåde til vurdering og behandling af cellulitis
AU2018244426B2 (en) 2017-03-28 2024-09-19 Endo Ventures Limited Improved method of producing collagenase

Also Published As

Publication number Publication date
CA3055041A1 (en) 2018-09-07
EP3589204B1 (en) 2025-04-16
KR20250021648A (ko) 2025-02-13
MX2023015506A (es) 2024-01-22
AU2025206433A1 (en) 2025-08-07
ES3036011T3 (en) 2025-09-11
PT3589204T (pt) 2025-07-18
JP2023120246A (ja) 2023-08-29
AU2022271390A1 (en) 2022-12-15
JP2020511284A (ja) 2020-04-16
US12403081B2 (en) 2025-09-02
AU2024201429A1 (en) 2024-03-21
US20180250217A1 (en) 2018-09-06
US20250352450A1 (en) 2025-11-20
AU2018226820A1 (en) 2019-09-19
FI3589204T3 (fi) 2025-07-03
AU2018226820B2 (en) 2022-12-08
US20210386644A1 (en) 2021-12-16
CN110545722A (zh) 2019-12-06
EP4591945A2 (en) 2025-07-30
US11123280B2 (en) 2021-09-21
MX2023008072A (es) 2023-07-17
US20240041744A1 (en) 2024-02-08
KR20230003601A (ko) 2023-01-06
KR102610801B1 (ko) 2023-12-05
AU2022271390B2 (en) 2024-01-18
IL301796A (en) 2023-05-01
WO2018160905A1 (en) 2018-09-07
KR20190126341A (ko) 2019-11-11
US11813347B2 (en) 2023-11-14
PL3589204T3 (pl) 2025-08-11
AU2024201429B2 (en) 2025-04-24
IL268985A (en) 2019-10-31
EP3589204A1 (en) 2020-01-08
BR112019018277A2 (pt) 2020-06-30
NZ756787A (en) 2025-08-29
DK3589204T3 (da) 2025-06-30
CN115969318A (zh) 2023-04-18
CN110545722B (zh) 2023-02-03
JP7558654B2 (ja) 2024-10-01

Similar Documents

Publication Publication Date Title
PT3589204T (pt) Aparelho e método de avaliação e tratamento da celulite
IL260382A (en) Device and cosmetic method to treat excessive sweating
GB201716311D0 (en) Apparatus and Method
GB201704736D0 (en) Treatment apparatus and method
GB2560552B (en) Method and apparatus
GB201714069D0 (en) Apparatus and method
SG11202002497QA (en) Surface treatment apparatus and surface treatment method
GB2566593B (en) Apparatus and method
GB201916607D0 (en) Apparatus and method
GB201801569D0 (en) Method and apparatus
ZA202000407B (en) Device and method for treating must
GB201713120D0 (en) Apparatus and method
GB2561913B (en) Method and apparatus
GB201706873D0 (en) Method and apparatus
GB201704360D0 (en) Apparatus and method
GB202209693D0 (en) Apparatus and method
GB2568663B (en) Method and apparatus
GB201704728D0 (en) Treatment apparatus and method
GB2559989B (en) Well access apparatus and method
GB201706874D0 (en) Method and apparatus
GB201716548D0 (en) Apparatus and method
GB201711561D0 (en) Method and apparatus
GB201700574D0 (en) Apparatus and method
GB202018224D0 (en) Method and Apparatus
GB201704718D0 (en) Treatment apparatus and method